| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.12 | 0.04 |